TABLE 5.
Duration (Days) | Mean SBP (mmHg) ( ± SD) | p value | Mean DBP (mmHg) ( ± SD) | p value | Mean PP (mmHg) ( ± SD) | p value | |||
---|---|---|---|---|---|---|---|---|---|
Uthever (N = 31) | Placebo (N = 31) | Uthever (N = 31) | Placebo (N = 31) | Uthever (N = 31) | Placebo (N = 31) | ||||
Baseline | 124.26 ± 14.73 | 128.90 ± 15.84 | 0.23 | 78.65 ± 8.76 | 79.06 ± 7.46 | 0.84 | 49.42 ± 17.46 | 51.19 ± 12.38 | 0.64 |
30 | 123.84 ± 15.49 | 127.52 ± 11.65 | — | 76.94 ± 9.00 | 79.19 ± 6.90 | — | 48.03 ± 12.46 | 48.32 ± 10.93 | — |
60 | 124.19 ± 12.03 | 126.26 ± 13.51 | — | 76.81 ± 8.30 | 77.84 ± 9.01 | — | 49.23 ± 11.09 | 48.10 ± 12.02 | — |
Mean diff (Baseline –Day 30) (p value) | −0.42 ± 11.10 (0.83) | −1.39 ± 14.76 (0.60) | 0.77 | −1.71 ± 7.63 (0.22) | 0.13 ± 8.09 (0.92) | 0.36 | −1.39 ± 18.37 (0.67) | −2.87 ± 13.75 (0.25) | 0.72 |
Mean diff (Baseline –Day 60) (p value) | −0.06 ± 10.31 (0.97) | −2.65 ± 14.72 (0.32) | 0.42 | −1.84 ± 8.51 (0.23) | −1.23 ± 9.90 (0.49) | 0.79 | −0.19 ± 18.59 (0.95) | −3.10 ± 14.02 (0.22) | 0.48 |
By Student “t” Test p > 0.05 was considered not significant.